Jump to content

Center for Biologics Evaluation and Research: Difference between revisions

Line 82: Line 82:
* [[Dermatologic and Ophthalmic Drugs Advisory Committee]] (DODAC)
* [[Dermatologic and Ophthalmic Drugs Advisory Committee]] (DODAC)
* [[Device Good Manufacturing Practice Advisory Committee]] (DGMPAC)
* [[Device Good Manufacturing Practice Advisory Committee]] (DGMPAC)
* [[Drug Safety and Risk Management Advisory Committee]
* [[Drug Safety and Risk Management Advisory Committee]]
* [[Endocrinologic and Metabolic Drugs Advisory Committee]]
* [[Endocrinologic and Metabolic Drugs Advisory Committee]]
* [[Gastrointestinal Drugs Advisory Committee]
* [[Gastrointestinal Drugs Advisory Committee]]
* [[Medical Devices Advisory Committee]] (MDAC) – 18 panels
* [[Medical Devices Advisory Committee]] (MDAC) – 18 panels
* [[Medical Imaging Drugs Advisory Committee]]
* [[Medical Imaging Drugs Advisory Committee]]